Enzyme Environmental Solutions Estimates in Excess of 100M for 2009
February 26 2009 - 1:57PM
Marketwired
Enzyme Environmental Solutions Inc. (PINKSHEETS: EESO) has set the
stage for a breakthrough year by harvesting technology and vendors
in medical, commercial/industrial and retail product formula lines.
"It's been a tremendous year and we're not even finished with
first quarter. In addition to the recent coup secured with our
exclusive retail partner, we've been underway on innovative
solutions for medical and industrial sectors in addition to the
successes we've had with Pit Solution and GC 2000 technologies,"
states Jared Hochstedler, CEO and President of the progressive
green biotech company. "We have reviewed existing licensing
agreements and product orders and have been conservative with
received Letters of Intent and projected manufacturing orders and
biotech licensing requests from several commercial vendors in
sectors anywhere among the steel industry, medical fields and water
treatment, among others and have estimated, moderately, projected
gross sales are in excess of $136,000,000.00 ($136M) by end of 4th
quarter, 2009. This does not include pending prospective contracts
with Southeast Asia and the multitude of formula applications
therein."
Hochstedler continues, "We have worked diligently to secure
alliances worldwide as part of an overall global strategy,
introducing formulas and other biotechnology IP and took a risk in
doing so; but it wasn't for a lack of vision. This was a large move
I felt strongly about pursuing based on several vendor inquiries.
The traditional model of simply getting products onto store shelves
wasn't big enough for our overall mission: 'Cleaner world. Safer
planet.'... It was an overall deliberate shift in market focus and
distribution avenues on the retail side... and aggressively
pursuing government agencies and entertaining solution requests
from vendors internationally."
It's certainly paid off for EESO. The company recently released
financials for Q3 and Q4 of 2008 on www.pinksheets.com and was
upgraded to a 'limited information' company. EESO is currently in
the process of fulfilling Pink OTC requirements toward 'current
information' status as part of its promise to increase transparency
and overall investor confidence as it paves the way for continued
success and growth in the Green Biotech market internationally.
The company looks forward to sharing news of this forthcoming
progress at tomorrow's Open House event at their Fort Wayne,
Indiana offices.
Safe Harbor: This release may contain forward-looking statements
within the meaning of the Private Securities Litigation Reform Act
of 1995. Statements contained in this release that are not
historical facts may be deemed to be forward-looking statements.
Investors are cautioned that forward-looking statements are
inherently uncertain. Actual performance and results may differ
materially from that projected or suggested herein due to certain
risks and uncertainties including, without limitation, ability to
obtain financing and regulatory and shareholder approvals for
anticipated actions.
Contact: Newbauer Media Relations Enzyme Environmental Solutions
Email: mark@enzymeconsultants.com
Enzyme Environmental Sol... (CE) (USOTC:EESO)
Historical Stock Chart
From Apr 2024 to May 2024
Enzyme Environmental Sol... (CE) (USOTC:EESO)
Historical Stock Chart
From May 2023 to May 2024